Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.8.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 12,645 $ 15,199
Accounts receivable, net 6,403 3,437
Other current assets 1,092 1,172
Total current assets 20,140 19,808
Property and equipment, net 634 654
Other intangible assets, net 32,292 33,105
Other long-term assets 31 31
Total assets 53,097 53,598
Current liabilities:    
Accounts payable 735 391
Accrued salaries and bonus 997 1,394
Other accrued expenses 5,077 5,004
Current liabilities from discontinued operations 985 1,302
Total current liabilities 7,794 8,091
Contingent consideration 1,272 1,349
Other long-term liabilities 4,266 4,289
Total liabilities 13,332 13,729
Commitments and contingencies (Note 6)
Stockholders’ equity:    
Preferred stock, $.01 par value; 5,000,000 shares authorized, no shares issued and outstanding
Common stock, $.01 par value; 100,000,000 shares authorized; 27,942,344 and 27,900,806 shares issued, respectively; 27,869,275 and 27,836,456 shares outstanding, respectively 279 278
Additional paid-in capital 173,659 173,062
Accumulated deficit (132,493) (131,800)
Treasury stock, at cost (73,069 and 64,350 shares, respectively) (1,680) (1,671)
Total stockholders’ equity 39,765 39,869
Total liabilities and stockholders’ equity $ 53,097 $ 53,598